One of the rarest but unfortunately undoubtedly the most dangerous complications in pharmacotherapy treatment of mental disorders is neuroleptic malignant syndrome (NMS). Most often it arises as a result of the use of antipsychotics, but there are also cases, described in the literature, of NMS which starts as a result of usage antidepressants such as mianserin, amoxapine, or fluoxetine. Neuroleptic malignant syndrome has also been found in patients diagnosed with Parkinson’s disease and parkinsonism, after abrupt discontinuation of usage of L-dopa and drugs that are dopamine receptor agonists (cabergoline, bromocriptine, pergolide, ropinirole, pramipexole, and amantadine). Symptoms that may suggest the occurrence of neuroleptic malignant...
Multiple sclerosis (MS) is a progressive inflammatory-demyelinating disease of the central nervous s...
Wprowadzenie do leczenia leków przeciwpsychotycznych drugiej generacji (SGAs) spowodowało, że w osta...
Wprowadzenie do leczenia leków przeciwpsychotycznych drugiej generacji (SGAs) spowodowało, że w osta...
One of the rarest but unfortunately undoubtedly the most dangerous complications in pharmacotherap...
Jednym z rzadszych, ale niewątpliwie najniebezpieczniejszych powikłań farmakoterapii stosowanej w ...
Jednym z rzadszych, ale niewątpliwie najniebezpieczniejszych powikłań farmakoterapii stosowanej w ...
Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. Clinical symptoms li...
Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. Clinical symptoms li...
Risperidone is approved by FDA for treatment of schizophrenia (1993) or to treat bipolar I (2003) ma...
Risperidone is approved by FDA for treatment of schizophrenia (1993) or to treat bipolar I (2003) ma...
Risperidone is approved by FDA for treatment of schizophrenia (1993) or to treat bipolar I (2003) ma...
Introduction: Schizophrenia is one of the most severe mental disorders. It is characterized by a chr...
Introduction. Noncompliance is one of most frequent reasons of discontinuation of therapy and lack o...
Multiple sclerosis (MS) is a progressive inflammatory-demyelinating disease of the central nervous s...
Multiple sclerosis (MS) is a progressive inflammatory-demyelinating disease of the central nervous s...
Multiple sclerosis (MS) is a progressive inflammatory-demyelinating disease of the central nervous s...
Wprowadzenie do leczenia leków przeciwpsychotycznych drugiej generacji (SGAs) spowodowało, że w osta...
Wprowadzenie do leczenia leków przeciwpsychotycznych drugiej generacji (SGAs) spowodowało, że w osta...
One of the rarest but unfortunately undoubtedly the most dangerous complications in pharmacotherap...
Jednym z rzadszych, ale niewątpliwie najniebezpieczniejszych powikłań farmakoterapii stosowanej w ...
Jednym z rzadszych, ale niewątpliwie najniebezpieczniejszych powikłań farmakoterapii stosowanej w ...
Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. Clinical symptoms li...
Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. Clinical symptoms li...
Risperidone is approved by FDA for treatment of schizophrenia (1993) or to treat bipolar I (2003) ma...
Risperidone is approved by FDA for treatment of schizophrenia (1993) or to treat bipolar I (2003) ma...
Risperidone is approved by FDA for treatment of schizophrenia (1993) or to treat bipolar I (2003) ma...
Introduction: Schizophrenia is one of the most severe mental disorders. It is characterized by a chr...
Introduction. Noncompliance is one of most frequent reasons of discontinuation of therapy and lack o...
Multiple sclerosis (MS) is a progressive inflammatory-demyelinating disease of the central nervous s...
Multiple sclerosis (MS) is a progressive inflammatory-demyelinating disease of the central nervous s...
Multiple sclerosis (MS) is a progressive inflammatory-demyelinating disease of the central nervous s...
Wprowadzenie do leczenia leków przeciwpsychotycznych drugiej generacji (SGAs) spowodowało, że w osta...
Wprowadzenie do leczenia leków przeciwpsychotycznych drugiej generacji (SGAs) spowodowało, że w osta...